PROJECTED LONG-TERM OUTCOMES IN PATIENTS WITH TYPE 1 DIABETES MELLITUS TREATED WITH FASTER-ACTING INSULIN ASPART VERSUS CONVENTIONAL INSULIN ASPART IN THE UK SETTING

被引：0
|
作者：
Russell-Jones, D. [1 ]
Buchs, S. [2 ]
Jensen, M. M. [2 ]
Hunt, B. [3 ]
Valentine, W. J. [3 ]
Heller, S. [4 ]
机构：
[1] Royal Surrey Cty Hosp, Guildford, Surrey, England
[2] Novo Nordisk AS, Soborg, Denmark
[3] Ossian Hlth Econ & Commun, Basel, Switzerland
[4] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1869
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB39
引用
收藏
页码：A671 / A671
页数：1
相关论文
共 50 条
  • [41] Cost impact analysis of mealtime fast-acting insulin aspart compared with insulin aspart in adults with Type 1 diabetes in the UK
    Pollock, R. F.
    Parekh, W.
    Watcham, S.
    Hallen, N.
    DIABETIC MEDICINE, 2019, 36 : 166 - 166
  • [42] EFFICACY AND SAFETY OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION OF FASTER ASPART COMPARED WITH INSULIN ASPART IN TYPE 1 DIABETES
    Klonoff, D.
    Evans, M.
    Lane, W.
    Kempe, H. P.
    Renard, E.
    DeVries, H.
    Graungaard, T.
    Hyseni, A.
    Battelino, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A32 - A33
  • [43] Performance of Fast-Acting Aspart Insulin as Compared to Aspart Insulin in Insulin Pump for Managing Type 1 Diabetes Mellitus: A Meta-Analysis
    Dutta, Deep
    Mohindra, Ritin
    Mahajan, Kunal
    Sharma, Meha
    DIABETES & METABOLISM JOURNAL, 2023, 47 (01) : 72 - 81
  • [44] CopenFast Trial-Fetal Growth and Glycemic Control in Pregnant Women with Type 1 or Type 2 Diabetes Using Faster-Acting Insulin Aspart or Insulin Aspart-A Randomized Controlled Trial
    Noergaard, Sidse K.
    Mathiesen, Elisabeth R.
    Norgaard, Kirsten
    Clausen, Tine D.
    Soholm, Julie
    Holmager, Pernille
    Do, Nicoline C.
    Damm, Peter
    Ringholm, Lene
    DIABETES, 2023, 72
  • [45] Improved long-term blood glucose control with insulin aspart versus human insulin in people with type 1 diabetes
    Home, PD
    Lindholm, A
    Riis, AP
    DIABETES, 1999, 48 : A358 - A358
  • [46] Faster-acting insulin aspart versus insulin aspart in the treatment of type 1 or type 2 diabetes during pregnancy and post-delivery (CopenFast): an open-label, single-centre, randomised controlled trial
    Norgaard, Sidse K.
    Soholm, Julie C.
    Mathiesen, Elisabeth R.
    Norgaard, Kirsten
    Clausen, Tine D.
    Holmager, Pernille
    Do, Nicoline C.
    Damm, Peter
    Ringholm, Lene
    LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (11): : 811 - 821
  • [47] Hypoglycaemia with mealtime fast-acting insulin aspart versus insulin aspart across two large type 1 diabetes trials
    De Block, C.
    Carlson, A.
    Rose, L.
    Gondolf, T.
    Gorst-Rasmussen, A.
    Boesgaard, T. W.
    Lane, W.
    DIABETOLOGIA, 2018, 61 : S31 - S32
  • [48] Efficacy and safety of fast-acting insulin aspart versus insulin aspart in children and adolescents with type 1 diabetes from Japan
    Kawamura, Tomoyuki
    Kikuchi, Toru
    Horio, Hiroshi
    Rathor, Naveen
    Ekelund, Magnus
    ENDOCRINE JOURNAL, 2021, 68 (04) : 409 - 420
  • [49] Reduced hypoglycaemia is observed with inhaled insulin versus subcutaneous insulin aspart in patients with type 1 diabetes mellitus
    Nikonova, E.
    Bode, B.
    Gill, J.
    Stewart, J.
    Blonde, L.
    DIABETOLOGIA, 2015, 58 : S449 - S450
  • [50] Faster-acting insulin aspart vs insulin aspart as part of basal-bolus therapy improves postprandial glycaemic control in uncontrolled type 2 diabetes: the onset® 2 trial
    Bowering, K.
    Case, C.
    Harvey, J.
    Reeves, M.
    Sampson, M.
    Strzinek, R.
    Bretler, D. -M.
    Bang, R. B.
    Bode, B. W.
    DIABETOLOGIA, 2016, 59 : S399 - S400
12345